Skip to content

Spinal anesthesia in cesarean section

Comparison of 1% 2-chloroprocaine alone or with fentanyl in subarachnoid block for cesarean section : A prospective, double blind, randomized, control trial - SAB in LSCS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016106
Enrollment
150
Registered
2018-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics Health Condition 2: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: GROUP CS: GROUP CS: 3ml (30mg) 1% preservative free plain 2 chloroprocaine + 0.5ml normal saline with total volume of 3.5 ml in subarachnoid space Control Intervention1: GROUP CF: GROUP

Sponsors

Dr S N Medical College Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: 1.Patients belonging to age group 18-35 years. 2.American Society Of Anaesthesiologists(ASA) grade 1 and 2. 3.Body Mass Index (BMI) between 20-35 kg/m2. 4.Patients undergoing elective caesarean section.

Exclusion criteria

Exclusion criteria: 1.Patients refusal 2.Known hypersensitivity to local anaesthetics 3.Patients with infection at the site of infection 4.ASA grade 3 & 4 patients 5.Patients with history of bleeding disorders or patients on anticoagulants 6.Parturient with pregnancy induced hypertension 7.Emergency delivery 8.BMI >35kg/m2 9.Patients with cardiac disease (like heart blocks, dysarrythmias), renal or other organ system disease which preclude choice of spinal anaesthesia. 10. Pre existing peripheral neuropathy or neurological deficit or psychiatric disease 11. Anatomical abnormality

Design outcomes

Primary

MeasureTime frame
Duration of analgesia.Timepoint: 24 hours

Secondary

MeasureTime frame
1.To assess onset and duration of sensory block . 2. To assess onset and duration of motor block . 3.To assess the level of sensory block. 4.To assess the level of motor block. 5. Consumption of analgesic in first 24 hrs. 6.To compare haemodynamics and respiratory parameters. 7.Quality of block. 8.Neonatal outcome(APGAR SCORE) 9.Patient satisfaction. 10.Any side effects or complications including TNS Timepoint: upto 6 months

Countries

India

Contacts

Public ContactDr Kusum Choudhary

Dr. S N Medical Collage Jodhpur

geetamanojkamal@gmail.com09414803554

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026